Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.71 | 27.16 |
| PEG Ratio (TTM) | -0.65 | 42.78 |
| P/S Ratio (TTM) | 1.26 | 7.35 |
| P/B Ratio (TTM) | 3.66 | 6.14 |
| P/FCF Ratio (TTM) | 11.14 | 22.85 |
| Price to 5YR AVG Earnings Ratio | 24.35 | 70.33 |
| Price to 5YR AVG FCF Ratio | 27.02 | 36.40 |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.17% | 6.17% |
| ROE (TTM) | 27.80% | 19.69% |
| Net Profit Margin (TTM) | 9.51% | 6.68% |
| ROIC 5YR AVG | 22.34% | 11.91% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 11.60% | -18.19% | 9.94% |
| Revenue | 0.97% | 11.83% | 5.62% |
| Net Income | 11.20% | -15.82% | 10.17% |
| Cash Flow | 14.97% | -29.50% | 84.56% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.08 | 1.57 |
| Quick Ratio (TTM) | 1.36 | 1.13 |
| D/E Ratio (TTM) | 0.80 | 0.94 |
| Interest Coverage (TTM) | 7.59 | 13.92 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 3.90 | 3.59 |
| LTL to 5YR AVG FCF | 5.84 | 6.68 |
| Shares Outstanding Growth 5YR AVG | -1.25% | 3.57% |